| Oosterkamp, H M |
| Active, not recruiting | 2 | 304 | Europe | Carbo/cyclo, Carboplatin, Cyclophosphamide, Carbo/cyclo + atezolizumab, Atezolizumab, Paclitaxel, Paclitaxel + Atezolizumab | The Netherlands Cancer Institute, Borstkanker Onderzoek Groep, Roche Pharma AG | Breast Cancer | 12/24 | 12/30 | | |
| Maas, Klaar |
ELDAPT, NCT02284308: Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy |
|
|
| Recruiting | N/A | 288 | Europe | Blood withdrawal | Maastricht Radiation Oncology, Dutch Society of Physicians for Pulmonology and Tuberculosis, Erasmus Medical Center, VieCuri Medical Centre, AstraZeneca, Dutch Cancer Society | NSCLC | 07/24 | 07/25 | | |
| Wiggenraad, Ruud |
| Completed | N/A | 80 | Europe | | Erasmus Medical Center, HollandPTC, Amsterdam University Medical Center, Leiden University Medical Center, Delft University of Technology, Medical Center Haaglanden | Astrocytoma, Grade II, Astrocytoma, Grade III, Oligodendroglioma, Oligodendroglioma, Anaplastic | 06/24 | 06/24 | | |
| Graaf, Pim de |
| Recruiting | 3 | 232 | Europe | Radiofrequency ablation, RFA, Ultrasound-guided radiofrequency ablation, Radioactive iodine, I-131 | Rijnstate Hospital, ZonMw: The Netherlands Organisation for Health Research and Development, University of Twente, Amsterdam UMC | Thyroid Nodule, Toxic or With Hyperthyroidism, Autonomous Thyroid Function, Thyroid Nodule; Hyperthyroidism, Radiofrequency Ablation, Iodine Hyperthyroidism, Iodine Adverse Reaction | 12/27 | 12/28 | | |
| Completed | N/A | 607 | Europe | Screening for trilateral retinoblastoma with MRI | Amsterdam UMC, location VUmc | Retinoblastoma | 09/23 | 09/23 | | |
| Recruiting | N/A | 4351 | Europe | Incidence and survival of trilateral retinoblastoma and the differences globally | Amsterdam UMC, location VUmc | Trilateral Retinoblastoma, Retinoblastoma | 12/27 | 12/29 | | |
| Broekman, Marieke LD |
BIOPSY, NCT05641220: Biopsy Versus Resection in Elderly Glioblastoma Patients. A Prospective Cohort Study. |
|
|
| Not yet recruiting | N/A | 325 | Europe | | Erasmus Medical Center | Glioblastoma | 01/27 | 01/27 | | |
| Jeurissen, FJF |
CrEATE, NCT06434896: Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC- Trial |
|
|
| Recruiting | N/A | 1320 | Europe | ctDNA analysis after surgery | UMC Utrecht, Personal Genome Diagnostics (PGDx), The Netherlands Cancer Institute | Circulating Tumor DNA, Recurrence, Colon Cancer Stage II | 03/35 | 03/35 | | |
| Recruiting | N/A | 50000 | Europe | | Dutch Colorectal Cancer Group | Colorectal Cancer | 01/50 | 01/51 | | |
| Giessen, Elsmarieke M van de |
| Not yet recruiting | N/A | 144 | Europe | Clinical management based on the index MRI and an additional [¹⁸F] FET PET scan | Veerle Ruijters, ZonMw: The Netherlands Organisation for Health Research and Development, Curium PET France | Glioblastoma, Radionecrosis of Brain | 12/27 | 12/27 | | |
